Moleculin Biotech share price logo

Moleculin Biotech

NASDAQ: MBRX

$0.77

-0.01

(-0.88%)

as on

Moleculin Biotech Stock Performance

as on September 19, 2026 at 2:15 pm IST

  • Day's Low

    Day's High

    $0.75
    $0.80
    downward going graph

    2.99%

    Downside

    3.48%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $0.16
    $15.75
    downward going graph

    79.12%

    Downside

    1937.25%

    Upside

    downward going graph

Moleculin Biotech share price movements today

Previous Close
$0.78
Open
$0.79
Volume
705.4K
Market Cap
$14.4M
Day's Low - High
$0.75 - $0.80
52 Week Low - High
$0.16 - $15.75

Moleculin Biotech Historical Returns

1 Month Return
+ 36.36 %
3 Month Return
-72.92 %
1 Year Return
-92.25 %
3 Year Return
-99.47 %
5 Year Return
-99.93 %

Moleculin Biotech Stock Fundamentals & Key Indicators

Check Moleculin Biotech market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$14.4M

EPS (TTM)

-17.13

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-0.05

Industry PE ratio

-2.37

PEG Ratio

-0.00017934270693606105

EBITDA

-30.2M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-816.56%

Moleculin Biotech Stock Valuation

Track how Moleculin Biotech P/E has moved over time to understand its valuation trends.

Moleculin Biotech in the last 5 years

  • Overview

  • Trends

Lowest (-3.15x)

December 31, 2021

Industry (-2.37x)

December 31, 2025

Today (-0.12x)

December 31, 2025

Highest (-0.12x)

December 31, 2025

LowHigh

Today’s Price to Earnings Ratio: -0.12x

Moleculin Biotech vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Moleculin Biotech with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
BUY$14.4M-99.93%-0.050.00%0.00%
BUY$63.1B-63.24%-19.81-12.57%0.00%
BUY$130.1B174.21%29.8186.04%0.00%
BUY$79.7B21.1%18.4884.86%0.48%

Stock Returns calculator for Moleculin Biotech Stock including INR - Dollar returns

The Moleculin Biotech stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Moleculin Biotech investment value today

Current value as on today

₹8,357

Returns

-₹91,643

(-91.64%)

Returns from Moleculin Biotech Stock

-₹92,321 (-92.32%)

Dollar Impact

₹678 (+0.68%)

Analyst Recommendation on Moleculin Biotech Stock

Based on 3 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 3 analysts, 100% of analysts recommend a 'BUY' rating for Moleculin Biotech. Average target price of $12

Moleculin Biotech Share Price Target

Get share price movements and forecasts by analysts on Moleculin Biotech.

What analysts predicted

93.56%UPSIDE

Target Price

$12

Current Price

$0.7731

Analyzed by

3 Analysts

Target

$12.00

Moleculin Biotech target price $12, a slight upside of 93.56% compared to current price of $0.7731. According to 3 analysts rating.

Indian Investors' Interest in Moleculin Biotech Stock

Search interest for Moleculin Biotech Stock has increased by 61% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:61% versus previous 30 day period

Moleculin Biotech Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
-
-
-
0
-
0
-
-
0
-
Operating Income
-6
-6
-7
-6
-5
-5
-5
-7
-7
-7
EBITDA
-4
-4
-10
-1
-6
-7
-25
15
-12
-7
Interest Expense
-
-
-
-
-
-
-
-
-
0
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-4
-4
-10
-1
-6
-7
-25
15
-12
-7
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-4
-4
-10
-1
-6
-7
-25
15
-12
-7
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Moleculin Biotech Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
-
-
-
-
-
Gross Profit
0
0
0
-
-
-
-
-
0
Operating Income
-8
-15
-17
-19
-22
-30
-29
-26
-25
EBITDA
-8
-14
-13
-19
-15
-28
-29
-21
-33
Interest Expense
-
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
Income Before Tax
-9
-11
-13
-17
-15
-29
-29
-21
-33
Income Tax Expense
-
-
0
-
-
-
-
-
-
Net Income
-9
-11
-13
-17
-15
-29
-29
-21
-33
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Moleculin Biotech Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-4
-4
-10
-1
-6
-7
-25
15
-12
-7
Operating Cash Flow
-6
-5
-6
-5
-4
-5
-7
-5
-6
-6
Investing Cash Flow
-
0
-
-
-
-
-
-
-
-
Financing Cash Flow
-
0
4
0
7
5
6
7
7
3
Change in Cash
-6
-5
-1
-5
3
0
0
2
1
-3

Moleculin Biotech Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-9
-11
-13
-17
-15
-29
-29
-21
-33
Operating Cash Flow
-7
-12
-17
-17
-18
-27
-24
-23
-22
Investing Cash Flow
0
0
0
0
0
0
0
0
-
Financing Cash Flow
10
12
20
22
74
0
4
4
27
Change in Cash
2
0
3
4
55
-27
-19
-19
4

Mutual Funds that own Moleculin Biotech Stock

Check out the Mutual Funds with significant holdings in Moleculin Biotech.

Funds
Holdings
Shares Held
Fidelity Concord Street Trust
0.081242%
15824
VANGUARD INDEX FUNDS
0.071205%
13869

Global Institutional Holdings in Moleculin Biotech

Funds
Holdings
Vanguard
0.22%

Moleculin Biotech News & Key Events

  • img

    Today's Timeline - 21 September

    Mon, 06:06 AM

    -

    Moleculin Biotech's Performance-based Restricted Stock Units under lock-up agreement ending on 22-SEP-2025, restricting stock sales.

Insights on Moleculin Biotech

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, MBRX stock has moved up by 8.1%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Moderna, Inc. Common Stock has given 44.3% return, outperforming this stock by 143.8%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 510.3% return, outperforming this stock by 602.6%

About Moleculin Biotech

Moleculin Biotech, Inc. is a clinical-stage pharmaceutical company dedicated to advancing therapeutic candidates designed to combat highly aggressive cancers and viral infections. Their primary investigational drug, Annamycin, is currently undergoing Phase 1/2 clinical trials. These trials aim to assess its efficacy against acute myeloid leukemia (AML) that has relapsed or is resistant to prior therapies, as well as malignancies that have spread to the lungs. WP1066, a prominent immune/transcription modulator for the company, is presently in Phase I studies, targeting both adult and pediatric brain tumors, pancreatic cancer, and other types of aggressive malignancies. Further, the firm is developing WP1220, an analog of WP1066, intended for topical application in treating cutaneous T-cell lymphoma. Another compound, WP1122, is under development for glioblastoma multiforme and COVID-19. Moleculin Biotech has established collaboration agreements and partnerships with organizations such as MD Anderson, Animal Life Sciences, LLC, and WPD Pharmaceuticals Sp z.o.o. The company was founded in 2015 and maintains its principal offices in Houston, Texas.
OrganisationMoleculin Biotech
Headquarters5300 Memorial Drive, Houston, TX, 77007, US
IndustryBiotechnology
CEOWalter V. Klemp
E-voting on sharesClick here to vote

Key Management of Moleculin Biotech

Name

Title

Mr. Walter V. Klemp

Chairman, President & CEO

Mr. Jonathan P. Foster CPA

Executive VP & CFO

Dr. Donald H. Picker Ph.D.

Chief Scientific Officer

Dr. Waldemar Priebe Ph.D.

Co-Founder, Founding Scientist & Chairman of Scientific Advisory Board

Dr. John Paul Waymack M.D., Sc.D.

Senior Chief Medical Officer

FAQs

What is Moleculin Biotech share price today?

Moleculin Biotech share price today is $0.77 as on at the close of the market. Moleculin Biotech share today touched a day high of $0.80 and a low of $0.75.

What is the 52 week high and 52 week low for Moleculin Biotech share?

Moleculin Biotech share touched a 52 week high of $15.75 on and a 52 week low of $0.16 on . Moleculin Biotech stock price today i.e. is closed at $0.77,which is 95.09% down from its 52 week high and 379.00% up from its 52 week low.

What is Moleculin Biotech's market capitalisation today?

Moleculin Biotech market capitalisation is $0.00T as on .

How to invest in Moleculin Biotech Stock (MBRX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Moleculin Biotech on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Moleculin Biotech Shares that will get you 1.9402 shares as per Moleculin Biotech share price of $0.77 per share as on September 19, 2026 at 8:45 am IST.

What is the minimum amount required to buy Moleculin Biotech Stock (MBRX) from India?

Indian investors can start investing in Moleculin Biotech (MBRX) shares with as little as ₹95.88 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹958.80 in Moleculin Biotech stock (as per the Rupee-Dollar exchange rate as on ). Based on Moleculin Biotech share’s latest price of $0.77 as on September 19, 2026 at 8:45 am IST, you will get 12.9349 shares of Moleculin Biotech. Learn more about fractional shares .

What are the returns that Moleculin Biotech has given to Indian investors in the last 5 years?

Moleculin Biotech stock has given -99.93% share price returns and 30.29% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?